ClinConnect ClinConnect Logo
Search / Trial NCT05521737

Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy

Launched by INSTITUTO MEXICANO DEL SEGURO SOCIAL · Aug 26, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Electroacupuncture Acupuncture Diabetic Polyneuropathy Diabetic Peripheral Neuropathy Diabetic Peripheral Neuropathic Pain Nerve Conduction Diabetic Pain

ClinConnect Summary

This clinical trial is looking at how electroacupuncture, a treatment that uses electrical stimulation along with acupuncture needles, can help reduce pain and improve quality of life for people with diabetic peripheral neuropathy. This condition often causes pain and discomfort in the feet and legs for individuals with type 2 diabetes. The study is currently recruiting participants from specific medical centers in Mexico City and aims to understand how this therapy affects nerve function and pain levels.

To join the trial, participants must have type 2 diabetes and show signs of diabetic peripheral neuropathy, which means they have nerve damage related to their diabetes. Unfortunately, those with type 1 diabetes, certain autoimmune diseases, or other serious health conditions are not eligible. If you decide to participate, you can expect to receive electroacupuncture treatments and be monitored for changes in your symptoms and nerve health. This study is an opportunity to explore a potential new way to manage pain from diabetic nerve damage.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with type 2 diabetes.
  • Patients with clinical diabetic peripheral polyneuropathy.
  • Patients with electrophysiological diagnosis of diabetic peripheral polyneuropathy in its different types of classification.
  • Exclusion Criteria:
  • Type 1 Diabetes or gestational diabetes.
  • Systemic autoimmune diseases.
  • Hematological disorders.
  • HIV diagnosis.
  • Cancer in treatment.
  • Pregnancy.
  • Other types of neurological disorders or neuropathies.
  • Intervention with acupuncture six months previously.
  • Patients with pacemarkers.

About Instituto Mexicano Del Seguro Social

The Instituto Mexicano del Seguro Social (IMSS) is a prominent public institution in Mexico, dedicated to providing comprehensive healthcare services and social security to its members. Established to enhance public health and welfare, IMSS plays a pivotal role in the advancement of medical research and clinical trials aimed at improving patient outcomes. By facilitating innovative studies, IMSS contributes to the development of new therapies and treatments, ensuring that the healthcare system remains at the forefront of scientific progress and responds effectively to the health needs of the population.

Locations

Mexico City, Cuauhtémoc, Mexico

Mexico City, Cuauhtémoc, Mexico

Mexico City, , Mexico

Patients applied

0 patients applied

Trial Officials

José de Jesús Peralta Romero, PhD

Principal Investigator

Instituto Mexicano del Seguro Social

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials